Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by BioTeckon Aug 19, 2020 11:19am

111 Views

Post# 31428383

RE:RE:RE:clinical trial dates

Wounded tibiofemoral, I said I wouldn't because I could buy it at. 28 if I wanted more. Clearly there are more people who agree with me and that's why we aren't trading past 31 because everyone knows the midam boys will knock it down so why bother. Till the midam mess is mopped up or a PP happens or (unlikely) a deal, we stay in this band. My two cents.

Bullboard Posts

98% energy efficiency: How Acceleware's EM Technology is transforming heat solutions